Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 26Urinary Bladder Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 13Ovarian Neoplasms 10Nasopharyngeal Carcinoma 9Biliary Tract Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 7Neoplasm Metastasis 7Cholangiocarcinoma 7Lymphoma, Large B-Cell, Diffuse 6Triple Negative Breast Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Osteosarcoma 3Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Urologic Neoplasms 2Rectal Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Gallbladder Neoplasms 2Colonic Neoplasms 2

Interventions

Nivolumab 2sacituzumab govitecan 1relatlimab 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1avelumab 1Vinblastine 1Specimen Handling 1Paclitaxel 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Disulfides 1Cystoscopy 1Cisplatin 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Invasive Bladder Urothelial Carcinoma × Gemcitabine × 30 days × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡